APA (7th ed.) Citation

Elazab, M., Hussien, M. A., Elshennawy, E. M., Nosair, N. A., & Amer, I. (2026). Serum fibroblast growth factor-19 as a diagnostic biomarker of hepatocellular carcinoma and indicator of portal vein thrombosis: A cross-sectional study. Egyptian Liver Journal, 16(1), 1. https://doi.org/10.1186/s43066-026-00530-7

Chicago Style (17th ed.) Citation

Elazab, Mostafa, Mohammed A. Hussien, Eslam M. Elshennawy, Nahla A. Nosair, and Ibrahim Amer. "Serum Fibroblast Growth Factor-19 as a Diagnostic Biomarker of Hepatocellular Carcinoma and Indicator of Portal Vein Thrombosis: A Cross-sectional Study." Egyptian Liver Journal 16, no. 1 (2026): 1. https://doi.org/10.1186/s43066-026-00530-7.

MLA (9th ed.) Citation

Elazab, Mostafa, et al. "Serum Fibroblast Growth Factor-19 as a Diagnostic Biomarker of Hepatocellular Carcinoma and Indicator of Portal Vein Thrombosis: A Cross-sectional Study." Egyptian Liver Journal, vol. 16, no. 1, 2026, p. 1, https://doi.org/10.1186/s43066-026-00530-7.